Invex Therapeutics Ltd. (AU:IXC) has released an update.
Invex Therapeutics Ltd. has announced the expiration of 400,000 options on April 8, 2024, without exercise or conversion. The options were set to expire at a strike price of $0.91. This development may influence the company’s capital structure and potentially impact shareholder value.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.
